Lasting Supply: Rebuilding Europe’s Antibiotic Manufacturing Resilience

Antibiotics are among the most essential building blocks of modern healthcare, yet their manufacturing and supply chains are under growing pressure. Decades of consolidation, cost‑driven procurement, and limited investment have left critical medicines increasingly exposed to disruption, even as demand remains stable and predictable.

This session explores how resilience in antibiotic manufacturing has eroded, and why this matters not only for public health, but for the long‑term sustainability of the pharmaceutical industry.